Publications

    1. Singh P, Chandra D, Gupta R, Rahman K, Sharma A, Gupta A, Nityanand S Circulating Micromegakaryocytes; Challenges and Clues to Diagnosis.Indian J Hematol Blood Transfus. 2020 Apr;36(2):411-413. doi: 10.1007/s12288-019-01201-x. Epub 2019 Oct 8.

    2. Chauhan P, Gupta A, Kumar S, Bishnu A, Nityanand S. Palmar-plantar erythrodysesthesia associated with high-dose methotrexate: Case report.Cancer Rep (Hoboken). 2020 Oct; 3(5):e1270. doi: 10.1002/cnr2.1270. Epub 2020 Aug 7.

    3. Ghoshal U, Kalra SK, Tejan N, Ranjan P, Dey A, Nityanand S. Prevalence and Genetic Characterization of Cryptosporidium and Microsporidia Infecting Hematological Malignancy Patients. Acta Parasitol. 2020 Nov 13. doi: 10.1007/s11686-020-00307-x. Online ahead of print.

    4. Rahman K, Chandra D, Singh MK, Gupta R, , Sharma A Paul P , Kumar Sharma S, and Nitynanad S. Mutant specific anti-calreticulin antibody (CAL2) immunohistochemistry as screening test for calreticulin (CALR) mutant testing. Int J Lab Hematol, 2020; In Press.

    5. Mittal N, Gupta R, Rahman K, Sing P, Panda I, and Nityanand S. A case of paraneoplastic hyper leukocytosis closely mimicking chronic neutrophilic leukemia. J Cancer Res Ther, 2020, 16:186-188.

    6. Rahman K, Singh MK, Gupta R, Dutta S, Nityanand S. De novo Philadelphia chromosome positive myelodysplastic syndrome: Report of two cases with brief literature review. J Cancer Res Ther, 2020; 16: 173-176.

    7. Rahman K, S Gupta, R Gupta, and Nityanand S. Microfilarae in bone marrow aspirate of a case of myelofibriosis: a cause or coincidence? J Cancer Res Ther, 2020; 16: 164-166.

    8. Srivastava J, Chaturvedi CP, Rahman K, Gupta R , Sharma A, Gupta A, Chandra D, Yadav S, Singh MK, Nityanand S. Differential expression of miRNAs and their target genes; Exploring a new perspective of acquired aplastic anemia pathogenesis. Int J Lab Hematol, 2020, Jun 3. doi: 10.1111/ijlh.13245. Online ahead of print.

    9. Gupta R, Sanjeev, Rahman K, Parashar Y, Singh M K, Chandra D, Gupta A, Nityanand S. Morphological characteristics, cytogenetic profile and outcome of RUNX1-RUNX1T1 positive Acute Myeloid Leukemia; Experience of an Indian tertiary care center. Int J Lab Hematol. 2020 Feb;42(1):37-45. doi: 10.1111/ijlh.13121. Epub 2019 Nov 14.PMID: 31725954

    10. Chandra D, Gupta R, Rahman K, Singh MK, Nityanand S. Clinico-pathological spectrum of Glanzmann Thrombasthenia. Res Pract Thromb Haemost, 2020; 4 (Suppl 1): PB1503

    11. Bishnu A, Yadav S, Chandra D, Singh MK, Gupta A, Rahman R, Gupta R, Kashyap R, Nityanand S. Primary AL Amyloidosis: Clinical presentation & outcome from a tertiary care hospital in North India. Indian J Hematol Blood Transfus, 2019; 35: S106

    12. Paswan V, Chandra D, Rahman K, Gupta R, Kumar S, Gupta A, Nityanand S, Singh MK. Diagnostic capabilities of SPEP, IFE and SFLC assay in intact immunoglobulin plasma cell Dyscrasia. Indian J Hematol Blood Transfus, 2019; 35(1) S 117

    13. Hasan F, Gupta A, Kumar S, Gupta R, Rahman K, Chandra D, Nityanand S. CNS complications in acute lymphoblastic leukemia:a tertiary care centre experience from north India. Indian J Hematol Blood Transfus, 2019; 35: S10

    14. Sanjeev, Gupta R, Gupta A, Garg A, Rahman K, Nityanand S. Morphological characteristics, cytogenetic profile and treatment outcome of AML1-ETO positive acute myeloid leukemia; Indian perspective. Hemasphere, 2019; 3: s1807.

    15. Sanjeev, Tandon S, Gupta R, Nityanand S. Sudden onset hearing and visual loss: An unusual presentation of chromic myeloid leukemia. Hemasphere, 2019; 3: s1889-90

    16. Minocha E., Sinha R.A., Jain M. Chaturvedi CP, Nityanand S. Amniotic fluid stem cells ameliorate cisplatin-induced acute renal failure through induction of autophagy and inhibition of apoptosis. Stem Cell Res Ther 10, 370 (2019). https://doi.org/10.1186/s13287-019-1476-6

    17. Singh, P. Chandra D., Gupta R. Rahman R, , Sharma A, Gupta A , Nityanand S. Circulating Micromegakaryocytes; Challenges and Clues to Diagnosis. Indian J Hematol Blood Transfus (2019). https://doi.org/10.1007/s12288-019-01201-x

    18. JainM, Minocha E, , Tripathi NK , Singh N , Chaturvedi CP, Nityanand S. Comparison of the Cardiomyogenic Potency of Human Amniotic Fluid and Bone Marrow Mesenchymal Stem Cells. Intl J of Stem Cells, 2019, Nov 30;12(3):449-456. doi: 10.15283/ijsc18087.

    19. Sharma A, George B, Subhash C, Bhurani D, Choudhary D, Easow J, John J, Kumar L, Sidharthan N, Malhotra P, Ahmed R, Raj R, Bhargava R, Yadav SP, Damodar S, Nityanand S, Bhat S, Saikia T, Seth T, Nair V, Mathews V. Summary of the Highlights of 2019 ASTCT Meeting by iNDUS BMT Group at Chennai, India. Indian J Hematol Blood Transfus. 2019 Jul; 35(3):409-415. doi: 10.1007/s12288-019-01152-3. Epub 2019 Jun 21. Review

    20. Minocha E, Chaturvedi CP, Nityanand S. Renogenic characterization and in vitro differentiation of rat amniotic fluid stem cells into renal proximal tubular- and juxtaglomerular-like cells. In Vitro Cell Dev Biol Anim. 2019 Feb; 55(2):138-147. doi: 10.1007/s11626-018-00315-2. Epub 2019 Jan 15. PMID: 30645697

    21. Kumar P, Rahman K, Hussein N, Gupta R, Nityanand S. Primary prostatic non-Hodgkin's lymphoma presenting with features of prostatism. J Cancer Res Ther. 2019 Mar; 15(Supplement):S178-S179. doi: 10.4103/jcrt.JCRT_886_16. No abstract available. PMID: 30900645

    22. Garg A, Gupta A, Mishra A, Singh M, Yadav S, Nityanand S. Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: Experience from a tertiary care centre in North India. PLoS One. 2018 Dec 27; 13(12):e0209832. doi: 10.1371/journal.pone.0209832. eCollection 2018. PMID: 30589898

    23. Gupta A, Mishra P, Nityanand S. Serum albumin predicts survival in Indian adult diffuse large B cell lymphoma patients in the rituximab era. Indian J Med Paediatr Oncol 2018 DOI 10.4103/ijmpo.ijmpo_96_18

    24. Gupta A, Garg A, Sharma A, Mishra A, Sanjeev, Nityanand S. Response to Induction Chemotherapy Predicts Survival in AML: A Single Centre Experience from North India. Indian Journal of Cancer Education and Research, 6 (2), July - December 2018 DOI: http://dx.doi.org/10.21088/ijcer.2321.9815.6218.2

    25. Kumar P, Rahman K, Kumari S, Singh MK, Gupta R, Nityanand S. Priapism as a rare presentation of chronic myeloid leukemia. J Cancer Res Ther. 2018 Oct-Dec; 14(6):1442-1443. doi: 10.4103/0973-1482.199388.

    26. Chaturvedi CP, Tripathy NK, Minocha E, Sharma A, Rahman K, Nityanand S. Altered Expression of Hematopoiesis Regulatory Molecules in Lipopolysaccharide-Induced Bone Marrow Mesenchymal Stem Cells of Patients with Aplastic Anemia.Stem Cells Int. 2018 Oct 17; 2018:6901761. doi: 10.1155/2018/6901761. eCollection 2018. PMID: 30416525.

    27. Gupta R, Harankhedkar S, Rahman K, Singh MK, Chandra D, Mittal N, Gupta A, Nityanand S. Prevalence of Chromosome 7 Abnormalities in Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Single Center Study and Brief Literature Review. Indian J Hematol Blood Transfus. 2018 Oct; 34(4):602-611. doi: 10.1007/s12288-018-0941-1. Epub 2018 Mar 5. PMID: 30369728

    28. Nair R, Kakroo A, Bapna A, Gogia A, Vora A, Pathak A, Korula A, Chakrapani A, Doval D, Prakash G, Biswas G, Menon H, Bhattacharya M, Chandy M, Parihar M, Vamshi Krishna M, Arora N, Gadhyalpatil N, Malhotra P, Narayanan P, Nair R, Basu R, Shah S, Bhave S, Bondarde S, Bhartiya S, Nityanand S, Gujral S, Tilak TVS, Radhakrishnan V. Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group. Indian J Hematol Blood Transfus. 2018 Jul; 34(3):398-421. doi: 10.1007/s12288-018-0991-4. Epub 2018 Aug 3. Review. PMID: 3012754.

    29. Tripathy NK, Rizvi SHM, Singh SP, Garikpati VNS, Nityanand S. Cardiomyogenic Heterogeneity of Clonal Subpopulations of Human Bone Marrow Mesenchymal Stem Cells. J Stem Cells Regen Med. 2018 May 30; 14(1):27-33. eCollection 2018. PMID: 30018470.

    30. Rahman K, Gupta R, Harankhedkar S, Gupta T, Sarkar MK, Nityanand S. Utility of CD157 as a Common Leukocytes Marker for Paroxysmal Nocturnal Hemoglobinuria Screening in a Single Tube Five Color Combination. Indian J Hematol Blood Transfus. 2018 Apr; 34(2):304-309. doi: 10.1007/s12288-017-0867-z. Epub 2017 Aug 22.

    31. Gupta R, Rahman K, Singh MK, Kumari S, Yadav G, Nityanand S. Clinico-Pathological Spectrum and Novel Karyotypic Findings in Myelodysplastic Syndrome: Experience of Tertiary Care Center in India. Mediterr J Hematol Infect Dis. 2017 Aug 16; 9(1):e2017048. doi: 10.4084/MJHID.2017.048. eCollection 2017.

    32. Thekkudan SF and Nityanand S. Nilotinib induced avascular necrosis of femoral head in an adult chronic myeloid leukemia patient. J Clin Orthop Trauma. 2018 Jun; 9 (Suppl 2):S26-S28. doi: 10.1016/j.jcot.2017.11.015. Epub 2017 Nov 24.

    33. Gupta T, Gupta R, Mittal N, Rahman K, Nityanand S. B-acute Lymphoblastic Leukemia with Bright CD45 and Moderate Side Scatter Simulating Monocytoid Population: An Unusual Phenotype. Indian J Hematol Blood Transfus. 2018 Apr; 34 (2):358-359. doi: 10.1007/s12288-017-0896-7. Epub 2017 Oct 28. No abstract available.

    34. Rahman K, Gupta R, Harankhedkar S J, Gupta T, Sarkar M K, Nityanand S. Utility of CD157 as a Common Leukocyte Marker for Paroxysmal Nocturnal Hemoglobinuria Screening in a Single Tube 5 Color Combinations. Indian J Hematol Blood Transfus. 2018 Apr; 34(2):304-309. doi: 10.1007/s12288-017-0867-z. Epub 2017 Aug 22

    35. Garikipati VNS, Singh SP, Mohanram Y, Gupta AK, Kapoor D, Nityanand S. Isolation and characterization of mesenchymal stem cells from human fetus heart. PLoS One. 2018 Feb 8; 13(2):e0192244. doi: 10.1371/journal.pone.0192244. eCollection.

    36. Gupta R, Mittal N, Rahman K, Sharma A, Singh P, Kumar S, Nityanand S. Rare BCR-ABL1 transcript in a RUNX1-RUNX1T1-positive de novo acute myeloid leukemia: The chicken and egg tale. Int J Lab Hematol. 2018 Apr; 40(2):e24-e27. doi: 10.1111/ijlh.12779. Epub 2018 Feb 2. No abstract available. PMID: 29393574

    37. Mittal N, Gupta R, Rahman K, Gupta T, Nityanand S. Co-existence of myeloid neoplasm and monoclonal gammopathy; case series and review of literature. Hematol Oncol Stem Cell Ther. 2017 Dec 6. pii: S1658-3876(17)30121-8. doi: 10.1016/j.hemonc.2017.11.002. [Epub ahead of print]

    38. Rahman K, Gupta R, Singh M K, Sarkar M K, Gupta A, Nityanand S. The triple negative profile (CD34/HLADR/CD11b Negative), rapidly and specifically identifies acute promyelocytic leukemia. Int J Lab Hematol. 2018 Apr;40(2):144-151. doi: 10.1111/ijlh.12754. Epub 2017 Oct 6.

    39. Gupta R, Rahman K, Singh MK, Kumari S, Yadav G, Nityanand S. Clinico-Pathological Spectrum and Novel Karyotypic Findings in Myelodysplastic Syndrome: Experience of Tertiary Care Centre in India. Mediterr J Hematol Infect Dis. 2017 Aug 16; 9(1):e2017048. doi: 10.4084/MJHID.2017.048. eCollection 2017.

    40. Singh SP, Jadhav SH, Chaturvedi CP, Nityanand S. Therapeutic efficacy of multipotent adult progenitor cells versus mesenchymal stem cells in experimental autoimmune encephalomyelitis. Regen Med. 2017 Jun 16. doi: 10.2217/rme-2016-0109. [Epub ahead of print].

    41. Rahman K, Gupta R, Yadav G, Husein N, Singh MK, Nityanand S. Fluorescent Aerolysin (FLAER)-based paroxysmal nocturnal hemoglobinuria (PNH) screening: a single center experience from India. Int J Lab Hematol. Jun; 39 (3):261-271. doi: 10.1111/ijlh.12619. Epub 2017 Apr 22.

    42. Gupta R, Rahman K, Singh MK, Surabhi, Yadav G, Nityanand S. Utility of a single tube six color flow cytometry panel for the diagnosis of Myelodysplastic syndrome: Experience of a tertiary care centre in India. Int J Hematol Oncol Stem Cell Res. 2018 Jan 1; 12(1):29-34.85.

    43. Thekkudan SF and Nityanand S. Development of Psoriasis Vulgaris in a Chronic Myeloid Leukemia Patient on Second-Generation Tyrosine Kinase Inhibitor Therapy. J Leuk, 2017, 5(2): 229. doi:10.4172/2329-6917.1000229.

    44. Garg A, Yadav S and Nityanand S. Isolated Gastrointestinal Graft versus Host Disease in a Patient of Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation. Ann Hematol Oncol. 2017, 4(4): 1146-48.

    45. Rahman K, Kumar P, Gupta R, Singh MK, Nityanand S. Role of CD200 in differential diagnosis of mature B-cell neoplasm. Int J Lab Hematol. 2017 Aug; 39(4):384-391. doi: 10.1111/ijlh.12637. Epub 2017 Apr 19.

    46. Yanamandra U, Khattry N, Kumar S, Raje N, Jain A, Jagannath S, Menon H, Kumar L, Varma N, Varma S, Saikia T, Malhotra P; for IMAGe Group. Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference. Indian J Hematol Blood Transfus. Mar; 33(1):15-21. doi: 10.1007/s12288-016-0773-9. Epub 2017 Jan 2. Review.

    47. Authors' response.Nair V, Madan H, Sofat S, Ganguli P, Jacob MJ, Datta R, Bharadwaj P, Sarkar RS, Pandit AJ, Nityanand S, Goel PK, Garg N, Gambhir S, George PV, Chandy S, Mathews V, George OK, Talwar KK, Bahl A, Marwah N, Bhatacharya A, Bhargava B, Airan B, Mohanty S, Patel CD, Sharma A, Bhatnagar S, Mondal A, Jose J, Srivastava A, 2016; for MI3 Trial. Indian J Med Res., 143(6):833. doi: 10.4103/0971-5916.192081. No abstract available.

    48. Mittal N, Gupta R, Rahman K, Singh P, Nityanand S. A case of paraneoplastic hyperleukocytosis closely mimicking chronic neutrophilic leukaemia. J Cancer Research and Therapeutics, 2017, Ahead of Print

    49. Rahman K, Surabhi, Gupta R, Singh MK, Yadav G Kumari N, Nityanand S. Atypical Presentation of Hairy cell Leukemia- Significance of CD200 on flow cytometry. Journal of Cancer Research and Therapeutics, 2017, Ahead of Print.

    50. Nityanand S, Tripathy NK, Chaturvedi CP, Minocha E, Sharma A, Rahman K. Altered expression of hematopoiesis regulatory genes in the bone marrow mesenchymal stem cells of patients of aplastic anemia. Blood 2016, 128: 3904.

    51. Rahman K, Gupta R, Singh MK, Yadav G, Kumari S, Kumar P, Nityanand S. Clinico pathological profile and role of flow cytometry in the diagnosis of myelodysplastic syndrome: An experience of a tertiary care centre of north India. Blood, 2016; 128: 2003.

    52. Singh P, Gupta R, Rahman K, Sarkar MK, Mittal N, Nityanand S. A Simple Four Color Antibody Panel to differentiate the neoplastic nature of Plasma cells by Flow Cytometry. Indian J Hematol Blood Transfus; 2016; 32: S451

    53. Kumar P, Bansal S, Patra PK, Nityanand S, Kashyap R, Rahman K, Gupta R, Gupta A, H. Lal L. Unusual Presentation of Acute Myeloid Leukemia as Facial Nerve Palsy and Paraparesis—Report of 3 Cases. Indian J Hematol Blood Transfus 2016; 32: S436

    54. Rahman K, Sharma A, Misra A, Gupta R, Singh MK, Sanjeev, Nityanand S. BCR-ABL positivity in acute lymphoblastic leukaemia. Indian J Hematol Blood Transfus, 2016; 31:S6

    55. Rahman R, Kumar P, Yadav G, Singh MK, Gupta R, Nityanand S. Utility of CD200 in diagnosis of Mature B Cell neoplasm. Haematologica, 2015; 100(s1): 245

    56. Harankhedkar SJ, Gupta R, Rahman R, Yadav G, Sarkar MK, Gupta T, Gupta A, Nityanand S. HLA-DR and CD34 dual negative acute myeloid leukemia: A distinct subset of leukemia or just a phenotype. Indian J Hematol Blood Transfus; 2016; 32: S 461

    57. Rahman K, Gupta R, Sarkar MK, Gupta G, Nityanand S. The Triple Negative profile (CD34/HLADR/CD11b) rapidly and specifically identifies an APML. Indian J Hematol Blood Transfus, 2016; 32: S453

    58. Gupta R, Aggarwal G, Rahman K, Singh MK, Nityanand S. Acute Myeloid Leukemia following radioiodine therapy: Case report and brief literature review. Clin Cancer Investig J, 2016, 5: 246-9.

    59. Singh MK, Gupta R, Rahman K, Yadav G, Sharma A, Nityanand S. De Novo Philadelphia Positive Acute Myeloid Leukemia with Extensive Basophilia: A Diagnostic Dilemma. Indian J Hematol Blood Transfus. 2016, 32(Suppl 1):86-8. doi: 10.1007/s12288-016-0640-8.

    60. Thekkudan SF, Kumar P, Nityanand S. Voriconazole-induced skeletal fluorosis in an allogenic hematopoietic stem cell transplant recipient. Ann Hematol.2016, 95(4):669-70. doi: 10.1007/s00277-016-2603-4. No abstract available.

    61. Singh MK, Gupta R, Rahman K, Kumar S, Sharma A, Nityanand S. Co-existence of AML1-ETO and BCR-ABL1 transcripts in a relapsed patient of acute myeloid leukemia with favorable risk group: A coincidence or clonal evolution? Hematol Oncol Stem Cell Ther. 2017 Mar; 10(1):39-41. doi: 10.1016/j.hemonc.2015.12.003. Epub 2016 Jan 16.

    62. Singh A, Nityanand S, Sonker A, Kumar S. Successful use of the cell separator hemonetics multicomponent collection system+ for therapeutic thrombocytapheresis in a low body weight child of essential thrombocythemia. Asian J Transfus Sci., 2015.9(2):207-9. doi: 10.4103/0973-6247.162722.

    63. Gupta AK, Jadhav SH, Tripathy NK, Nityanand S. Fetal kidney cells can ameliorate ischemic acute renal failure in rats through their anti-inflammatory, anti-apoptotic and anti-oxidative effects. PLoS One, 2015, June 18; 10(6):e0131057.doi: 10.1371/journal.pone.0131057. eCollection 2015.

    64. Nair V, Madan H, Sofat S, Ganguli P, Jacob MJ, Datta R, Bharadwaj, Sarkar RS, Pandit AJ, Nityanand S, Goel PK, Garg N, Gambhir S, George PV, Chandy S, Matthews V, George OK, Talwar KK, Bahl A, Marwah N, Bhatacharya A, Airan B, Bhargava B, Mohanty S, Patel CD, Sharma A, Bhatnagar, Mondal A, Jose J, Srivastava A, MI3 Trial. Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction - MI3 trial (mononuclear infusion in myocardial infarction, multi-centric-trial, India). Indian J Med Res., 2015, Aug;142(2):165-74. doi: 10.4103/0971-5916.164245.

    65. Gupta AK, Jadhav SH, Tripathy NK, Nityanand S, 2015. Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis. World J Stem Cells 2015, 7:776-788

    66. Singh A, Verma A, Nityanand S, Chaudhary R, Elhence P. Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity. Asian J Transfus Sci, 2015, 9(1):70-3. doi: 10.4103/0973-6247.150956.

    67. Prasad K, Sharma A, Garg A, Mohanty S, Bhatnagar S, Johri S, Singh KK, Nair V, Sarkar RS, Gorthi SP, Hassan KM, Prabhakar S, Marwaha N, Khandelwal N, Misra UK, Kalita J, Nityanand S: InVEST Study Group. Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial. Stroke 2014, 45(12): 3618-24. doi: 10.1161/ STROKEAHA.114.007028. Epub 2014 Nov 6.

    68. Garikipati VN, Jadhav S, Pal L, Prakash P, Dikshit M, Nityanand S. Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: an in vivo serial pinhole gated SPECT-CT study in rats. PLoS One. 2014, Jun 27; 9(6):e100982.

    69. Tripathy NK, Singh SP, Nityanand S. Enhanced adipogenicity of bone marrow mesenchymal stem cells in aplastic anemia. Stem Cells Int. 2014:276862. doi: 10.1155/2014/276862. Epub 2014 Apr 30

    70. Gupta R, Hussain N, Rahman K, Nityanand S. Plasma cell myeloma with unusual morphology--a series of 6 cases. Eur J Haematol. 2014, 93(2):165-70.

    71. Elhence P, Chaudhary RK, Nityanand S. Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Blood Transfus. 2014 Apr; 12(2):180-6. doi: 10.2450/2013.0064-13. Epub 2013 Nov 14.

    72. Francisco JC, Cunha RC, Simeoni RB, Guarita-Souza LC, Ferreira RJ, Irioda AC, Souza CMCO, Srikanth GVN, Nityanand S, Chachque JC, de Carvalho CAT. Amniotic membrane as a potent source of stem cells and a matrix for engineering heart tissue. J. Biomedical Science and Engineering. 2013, 6: 1178-1185.

    73. Singh A, Chaudhary R, Nityanand S. Successful management of acute bleeding in essential thrombocythemia using automated cell separator. Transfus Apher Sci.2013, 50(1):56-8.

    74. Mishra MN, Pandey R, Dinda A, Nityanand S. A peculiar case of splenic marginal zone lymphoma and review of literature. Iran J Immunol., 2013, 10(3):186-9.

    75. Singh SP, Tripathy NK, Nityanand S. Comparison of phenotypic markers and neural differentiation potential of multipotent adult progenitor cells and mesenchymal stem cells. World J Stem Cells 2013, 5(2): 53-60.

    76. Srikanth GV, Tripathy NK, and Nityanand S. Fetal cardiac mesenchymal stem cells express embryonal markers and exhibit differentiation into cells of all three germ layers. World J Stem Cells 2013, 5(1):26-33.

    77. Naseem S, Kaur S, Gupta R, Kashyap R, Nityanand S. Plasma cell leukemia: case series from a tertiary centre with review of literature, Indian J Hematol Blood Transfus. 2012, 28(1): 10-4.

    78. Srikanth GVN, Tripathy N, Nityanand S. Isolation and characterization of cardiac MSCs from rat fetal hearts. International J Regenerative Medicine. 2012, 1 (1):1-8.

    79. Ferreira RJ, Irioda AC, Cunha RC, Francisco JC, Guarita-Souza LC, Srikanth GV, Nityanand S, Rosati R, Chachques JC, De Carvalho KA. Controversies about the Chromosomal Stability of Cultivated Mesenchymal Stem Cells: Their Clinical Use is it Safe? Curr Stem Cell Res Ther. 2012, 7(5): 356-363.

    80. Srikanth GVN, Prakash P, Tripathy N, Dikshit M, Nityanand S. Establishment of a rat model of myocardial infarction with a high survival rate: A suitable model for evaluation of efficacy of stem cell therapy. Journal of Stem Cells & Regenerative Medicine. 2009, 5(1):1-6.

    81. Das SS, Nityanand S, Chaudhary R. Clinical and serological characterization of autoimmune hemolytic anemia in a tertiary care hospital in North India. Ann Hematol. 2009, 88(8):727-732.

    82. Naseem S, Gupta R, Kashyap R, Nityanand S. T-cell prolymphocytic leukemia: a report of two cases with review of literature. Indian J Hematology Blood Transfus. 2008, 24 (4), 178-181.

    83. Tripathy N, Chandran V, Garg NK, Sinha N, Nityanand S. Soluble endothelial cell adhesion molecules and their relationship with disease activity in Takayasu arthritis. J Rheumatol. 2008, 35(9):1842-5.

    84. Chauhan SK, Singh M, Nityanand S. Reactivity of gamma/delta T cells to human 60-kd head-shock Protein and their cytotoxicity to aortic-endothelial cells in Takayasu artritis, Arthritis Rheum. 2007, 56(8):2798-802.

    85. Talwar S. Nityanand S, Khan F., Agarwal S. Chimerism monitoring following allogeneic hematopoitic stem cell transplantation. Bone Marrow Transplant. 2007, 39 (9), 529-535.

    86. Gupta R, Naseem S, Kashyap R, Nityanand S. Immunophenotypic patterns in precursor T-cell neoplasm. Indian J Pathol Microbiol. 2007, 50 (1), 75-77.

    87. Gupta R, Pandey P, Choudhry R, Kashyap R, Mehrotra M, Naseem S, Nityanand S. A prospective comparison of four techniques for diagnosis of paroxysmal nocturnal Hemoglobinuria. Int J Lab Hematol. 2007, 29:119-126.

    88. Chauhan SK, Tripathy NK, Nityanand S. Antigenic targets and pathogenecity of anti-aortic endothelial cell antibodies in Takayasu arteritis, Arthritis Rheum. 2006, 54 (7): 2326-33.

    89. Tripathy NK, Gupta PC, Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu’s arteritis. Clin Immunol 2006, 118: (2-3), 154-158.

    90. Chauhan SK, Tripathy NK, Sinha N, Nityanand S. T-cell receptor repertoire of circulating gamma delta T-cells in Takayasu’s arteritis. Clin. Immunol. 2006, 118: (2-3), 243-249.

    91. Tripathy NK, Nityanand S, Vibhuti. Bone Marrow and blood plasma levels of IL-8 in aplastic anemia and their relationship with disease severity. Am J Hematol. 2005, 79:240-242.

    92. Dubey S, Shukla P, Nityanand S. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma patients with aplastic anemia. Ann Hematol. 2005, 84 (9): 572-577.

    93. Tripathy NK, Sinha N, Nityanand S. Interleukin-8 in Takayasu’s arteritis: plasma levels and relationship with disease activity. Clin Exp Rheumatol. 2004, 22(6): S 27-S30.

    94. Kumar Chauhan S, Kumar Tripathy N, Sinha N, Singh M, Nityanand S. Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu’s arteritis. Clin Exp Immunol. 2004, 138(3): 547-53.

    95. Tripathy NK, Chauhan SK, Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu’s arteritis. Clin Exp Immunol. 2004, 138(2), 369-374.

    96. Agarwal S, Khan F, Talwar S, Nityanand S. Short tandem repeat technology has diverse applications: individual identification, phylogenetic reconstruction, and chimerism based post hematopotic stem cell transplantation graft monitoring. Indian J Med Sci. 2004, 58(7): 297-304.

    97. Khan F, Phadke S, Nityanand S, Talwar S and Agrawal S. Use of ApoB' hyper variable region in studying mixed chimerism and maternal contamination in North Indian populations. J Clin Forensic Med. 2004, 11(4): 183-188.

    98. Wakhlu A, Agarwal V, Dabadghao S, Prasad KN, Nityanand S. Nocardiosis in Patients of Chronic Idiopathic Thrombocytopenic Purpura on Steroids. J Assoc Physicians India, 2004, 52: 591-593.

    99. Tripathy NK, Sinha N, Nityanand S. Anti annexin V antibodies in Takayasu’s arteritis: prevalence and relationship with disease activity. Clin Exp Immunol. 2003, 134: 360-364.

    100. Tripathy NK, Sinha N, Nityanand S. Antimonocyte antibodies in Takayasu’s arteritis: prevalence of and relation to disease activity. J Rheumatol. 2003, 30(9): 2023-2026.

    101. Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive therapy on clinical, Immunological, and angiographic outcome in active Takayasu’s arteritis. J Rheumatol, 2003, 30(8): 1793-1798.

    102. Dubey S, Nityanand S. Involvement of Fas and TNF pathways in induction of apoptosis of T cells by Antithymocyte globulin. Ann Hematol, 2003, 82(8): 496-499.

    103. Dubey S, Srivastava A, Nityanand S. Induction of apoptosis of peripheral blood mononuclear cells by antithymocyte globulin (ATG) in aplastic anemia: an in vivo and an in vitro study. Ann Hematol, 2002, 81(5): 249-253.

    104. Vibhuti, Tripathi N, Nityanand S. Massive apoptosis of bone marrow cells in aplastic anemia. Br J Hematology, 2002, 117(4): 993-994.

    105. Agarwal V, Dabadghao S, Misra MN, Nityanand S. Immunophenotypic subsets in acute lymphoblastic leukemia from a single center in North India: correlation with outcome to induction chemotherapy. Indian J Cancer, 2001, 38: 85-91.

    106. Tripathy NK, Upadhyaya S, Sinha N, Nityanand S. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu’s arteritis. J Rheumatol, 2001, 28(4): 805-8.

    107. Mustafa A, Nityanand S, Berglund L, Lithell H, Lefvert AK. Circulating immune complexes in 50-year old men as a strong and independent risk factor for myocardial infarction. Circulation, 2000, 102(21): 2576-81.

    108. Choudhary V, Nityanand S, Prasad, KN, Pandey R, Dabadghao S. Sweet’s syndrome and Pneumocystis carinii pneumonia: two sequlae of low dose cytosine arabinoside in a patient of acute myeloid leukemia. Eur J Hematology, 2000, 65(1): 72-73.

    109. Agarwal V, Nityanand S. Langerhans cell histiocytosis. J Assoc Physicians India, 2000, 48(3): 346-8.

    110. Chetri K, Aggarwal R, Sharma B, Nityanand S, Naik S.R. Ulceratine colitis and immune thrombocytopenia: a report of two cases. Indian J. Gastroenterol, 1999, 18:174.

    111. Nityanand S, Truedsson L, Mustafa A, Bergmark C, Lefvert A.K. Circulating immune complexes and complements C4 null alleles in patients operated on for premature atherosclerotic vascular disease. J Clin Immunol, 1999, 19(6), 406-413.

    112. Umesan CV, Kapoor A, Nityanand S, Tiwari S, Sinha N. Recurrent acute coronary events in a patient with primary antiphospholipid antibody syndrome: successful management with intracoronary stenting. Int J Cardiol, 1999, 71, 99-102.

    113. Nityanand S, Hamsten A, Lithell H, Holm G, Lefvert AK. C4 null alleles and myocardial infarction. Atherosclerosis, 1999, 143(2), 377-381.

    114. Ahmed E, Nityanand S, Awder M, Brismar K, Lefvert AK. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications. Clin Exp Immunol, 1999, 115(2): 255-9.

    115. Giscombe R, Nityanand S, Levin N, Grunewald J, Lefvert AK. Expanded T cell population in patients with Wegener’s granulomatosis: Characterization and correlates with disease activity. J Clin Immunol, 1998, 18(6): 404-13.

    116. Grunewald J, Halapi E, Wahlstom J, Giscombe R, Nityanand S, Sanjeevi C, Lefvert AK. T cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis. Blood, 1998, 92(10): 3737-44.

    117. Negi VS, Tripathi NK, Misra R, Nityanand S. Anti-endothelial cell antibodies in Scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol, 1998, 25(3): 462-468.

    118. Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK. Antibodies against cardiolipin and oxidatively modified LDL in 50-year old men predict myocardial infarction. Arterioscler Thromb Vasc Biol, 1997, 17(11): 3159-3163.

    119. Nityanand S, Mishra K, Srivastava S, Holm G, Lefvert AK. Autoantibodies against cardiolipin and enothelial cells in Takayasu’s Arteritis prevalence and Isotype distribution. Br J Rheumatol, 1997, 36:923-924.

    120. Nityanand S, Holm G, Lefvert AK. Immune Complex mediated vasculitis in hepatitis B and C infections and in the effect of anti-viral therapy. Clin Immunol Immunopathol, 1997, 82: 250-257.

    121. Nityanand S, Giscombe R, Srivastava S, Hjehnstron P, Sanjeevi CB, Sinha N, Grunewald J, Lefvert AK. A bias in the alphabeta T cell receptor variable region gene usage in Takayasu’s arteritis. Clin Exp Immunol, 1997, 107: 261-268.

    122. Giscombe R, Grunewald J, Nityanand S, Lefvert AK. T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol, 1995, 101:213-219.

    123. Nityanand S, Dawkins R, Lithell H, Holm G, Lefvert AK. C4 null alleles in a Swedish population. Eur J Immunogenetics, 1995, 22:435-441.

    124. Nityanand S, Bergmark C, de faire U, Swedenborg J, Holm G, Lefvert AK. Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Int Med, 1995, 238(5): 437-443.

    125. Agarwal R, Shahi H, Naik S, Naik SR, Nityanand S, Deka N, Batra JK. Fulminant hepatic failure with hepatitis E virus. J Hepatol, 1994, 21(6): 1156-1157.

    126. Nityanand S, Pande I, Bajpai VK, Singh L, Chandra M, Singh BN. Platelets in essential hypertension. Thromb Res, 1993, 72:447-454.

    127. Nityanand S, Singh VK, Shinohara T, Paul AK, Singh V, Agarwal PK, Agarwal SS. Cellular immune response of patients with uveitis to peptide M, a retinal S-antigen fragment. J Clin Immunology, 1993, 13:352-538.

    128. Das SK, Nityanand S, Sood K, Agarwal A, Kapoor R, Pant MC, Singh BN. Japanese B encepalitis with neurocysticerocosis. J Assoc Phys India, 1991, 39(8), 643-644.

    129. Nityanand S, Chandra M, Latika S, Tekwani BL, Bajpai VK, Shankar K, Singh BN. Platelet structure and function in essential hypertension. Eur J Pharmacol, 1990, 183 (5): 1823.

    130. Nityanand S, Tekwani BL, Chandra M, Shankar K, Singh BN. Kinetics of serotonin in essential hypertension. Life Sci, 1990, 46:367-372

    Book Chapter

    1. Triapthy NK, Nityanand S. “Regenerative Medicine”. Association of Physicians of India (API) Textbook of Medicine, 11th Edition, 2019.

    2. Nityanand S. “Bone marrow derived stem cells stem cells beyond hematopoietic reconstitution” in Monograph of XI Annual Ranbaxy Science Foundation Symposium on “Stem Cell Research: From Bench to Bedside”, 2005.

    3. Nityanand S. “Aplastic Anemia-Immune modulation” in Monograph of VIII Ranbaxy Science Foundation Symposium on “Advances in Hematopoietic Stem Cell Transplantation”, 2000.

    1. Garg A, Jain A, Kashyap R. Travel-acquired scrub typhus infection masked by dengue fever in a patient from nonendemic area. Journal of global infectious diseases 2018;10:114-114.

    2. Kashyap R, Awasthi NP, Gupta R. Clinical and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in Indian patients. Journal of Applied Hematology 2018;9:85-90.

    3. Halder R and Kashyap R. Hodgkin’s lymphoma with central nervous system disease at primary presentation. Pediatr Blood Cancer2016: 63:1130.

    4. Halder R, Malik R, Kashyap R. Warm antibody haemolytic anemia- a rare presentation of neonatal lupus. Lupus 2016: 0; 1-3.

    5. Kashyap R, Singh A, Kumar P. Prevalence of autoimmune hemolyticanemia in multiple myeloma: a prospective study. Asia‐Pacific Journal of Clinical Oncology2016;12:319-322.

    6. Kashyap R, Singh A, Pradeep K. Prevalence of autoimmune haemolytic anemia in multiple myeloma. A prospective study. Asia Pacific J Clin Oncol 2014. Sept (Eprint).

    7. Kashyap R, Kumar R, Kumar S. Cranial nerve palsy in multiple myeloma and solitary plasmacytoma. Asia‐Pacific Journal of Clinical Oncology 2010;6:251-255.

    8. Kashyap R, Pradhan M. Maternal and fetal outcome in pregnancy-associated pure red cell aplasia. Journal of Obstetrics and Gynaecology 2010;30:733-734.

    9. Kashyap R. Non-Hodgkin's Lymphoma-Associated Chylothorax: A Case Report and Literature Review. Asia Pacific Journal of Oncology &Hematology 2009;1:

    10. Kashyap R, Kumar R. Odontoid fracture in multiple myelomas. Asia‐Pacific Journal of Clinical Oncology 2007;3:224-225.

    11. Kashyap R, Chaudhary VP. Haematological manifestations of tuberculosis. Tuberculosis. 2006;32:372-379.

    12. Kashyap R, Gupta R. Extramedullary plasmacytoma. Indian Journal of Medical and Paediatric Oncology 2005;26:31.

    13. Kashyap R, Sarangi JN, Choudhry VP. Autoimmune hemolyticanemia in an infant with giant cell hepatitis. American journal of hematology.2006;81:199-201.

    14. Kashyap R, Sharma LM, Gupta S, Saxena R, Srivastava DN. Deep vein thrombosis in a patient with severe haemophilia A. Haemophilia 2006;12(1):87-89.

    15. Kashyap R, Sarangi JN, Choudhry VP. Autoimmune hemolyticanemia in an infant with giant cell hepatitis. American journal of hematology 2006;81:199-201.

    16. Kashyap R, Choudhry VP. Management of hemophilia in developing countries. Indian Journal of Pediatrics. 2001;68:151-157.

    17. Kashyap R, Choudhry VP, Mahapatra M, Chumber S, Saxena R, Postpartum acquired haemophilia: clinical recognition and management. Haemophilia 2001;7:327-330.

    18. Kashyap R, Choudhry VP, Pati HP. Danazol therapy in cyclic acquired amegakaryocytic thrombocytopenic purpura: a case report. American journal of hematology 1999;60:225-228.

    19. Kashyap R, Sarangi JN, Choudhry VP, Saxena R, Malhotra R. Pseudotumor of calcaneus: treatment with radiotherapy and replacement therapy. American journal of hematology 1998;57:263-264.

    20. Kashyap R, Sarangi JN, Choudhry VP. Pure red cell aplasia with thymoma. Journal of the Association of Physicians of India 1998;46;311-312.

    21. Kashyap R, Choudhry VP. Newer developments in hemophilia. Indian Journal od Practical Pediatrics 1997;5:303-306.

    22. Kashyap R, Kriplani A, Saxena R, Takkar D, Choudhry VP. Pregnancy in a patient of Glanzmann's thrombasthenia with antiplatelet antibodies. Journal of Obstetrics and Gynaecology Research 1997;23:247-250.

    23. Kashyap R, Venkatesh S, Choudhry VP. Post transfusion purpura in a thalassemic child. Indian paediatrics 1997;34:246-247.

    24. Kashyap R, Saxena R, Choudhry VP. Rare inherited coagulation disorders in India.Haematologia 1996;28:13

    25. Kashyap R, Choudhry VP. Delayed hemolytic transfusion reaction in a thalassemic child. Indian Journal of Pediatrics 1994;61:726-728.

1. Rahman K, Chnadra D, Singh MK, Gupta R, Sharma A, Paul P, Kumar S, Sharma S, NityanandS.Mutant specific anti calreticulin antibody (CAL2) immunohistochemistry as a screening test for Calreticulin mutation testing. Int J Lab Hematol 2020; 42(5):604-611

2. Rahman K, Gupta T, Chandra D, Gupta R, Singh MK, Sarkar M, Sanjeev, Nityanand S Hepatosplenic T cell Lymphoma diagnosed using flow Cytometry. A single centre study of 12 cases from North India.. J Can Res Ther 2020. Accepted. AOP

3. Gupta R, Sanjeev, Rahman K, Parashar Y, Singh M K, Chandra D, Gupta A, Nityanand S Morphological characteristics, cytogenetic profile and outcome of RUNX1-RUNX1T1 positive Acute Myeloid Leukemia; Experience of an Indian tertiary care center.. International Journal of Lab hematology. 2020:42 (1):37- 45 DOI: 10.1111/ijlh.13121.

4. Gupta R, Yadav S, Mittal N, Rahman K, Sharma A, Gupta A, Nityanand S. Clinico-pathological spectrum of Hairy cell leukemia: a single center study with brief review of Indian Literature. J Can Res Ther 2020;16:120-126.

5. Rahman K, Mittal N, Gupta R, Sanjeev, Gupta T, Gupta A, Nityannad S. Clinicopathological profile of Paroxysmal Nocturnal Hemoglobinuria Clone Positive Aplastic AnemiaPediatric Patients- A Single Centre Study from North India. Int J Lab Hematol. 2018; 40:604-610. doi: 10.1111/ijlh.12875.

6. Gupta R, Harankhedkar SJ, Rahman K, Singh MK, Mittal N, Gupta A, Nityanand S. Prevalence of chromosome 7 abnormalities in myelodysplastic syndrome and acute myeloid leukemia; a single center study and brief literature review. Ind J Hematol Blood Tranfus 2018; 34(4):602-611. https://doi.org/10.1007/s12288-018-0941-1

7. Rahman K, Gupta R, Harankhedkar S J, Gupta T, Sarkar M K, Nityanand S. Utility of CD157 as a Common Leukocytes Marker for Paroxysmal Nocturnal Hemoglobinuria Screening in a Single Tube 5 Color Combinations. Ind J of Hematol Blood Transfus 2018 Apr;34(2):304-309. doi: 10.1007/s12288-017-0867-z

8. Rahman K, Gupta R, Singh M K, Sarkar M K, Gupta A, Nityanand S. A triple negative profile (CD34/HLADR/CD11b Negative), rapidly and specifically identifies acute promyelocytic leukemia. International Journal of Lab Hematology 2018; 40(2):144-151. doi: 10.1111/ijlh.12754

9. Gupta R, Rahman K, Singh M K, Kumari S, Yadav G, Nityanand S. Clinico-pathological spectrum and novel karyotypic findings in myelodysplastic syndrome: Experience of a tertiary care centre in India. Mediterranean J of Hematology and Infectious Disease 2017 Aug 16;9(1):e2017048. doi: 10.4084/MJHID.2017.048

10. Rahman K, Kumar P, Singh M K, Gupta R, Nityanand S. Role of CD200 in differential diagnosis of Mature B cell neoplasm. Int Journal of Lab Hematol 2017; 39: 384-91.

11. Rahman K, Gupta R, Hussein N, Yadav G, Singh M K, Kumar P, Nityanand S. Fluorescent Aerolysin (FLAER) based paroxysmal nocturnal hemoglobinuria (PNH) screening- a single centre experience from India. Int J Lab Hematol 2017; 39(3):261-71.

12. Rahman K, Subramanian PG, Kadam P A, Galani K, Gadage V, Mittal N et al. Morphological spectrum of leukemic mantle cell lymphoma. Indian Journal of Pathology Microbiology 2012;55:66-71

13. Gupta A, Rahman K, Shahid M, Kumar A, Qaseem S M D, Hasan S A et al. Sonographic assessment of cervical lymphadenopathy: Role of high resolution and color doppler imaging. Head and Neck 2011;33(3):297-302.

14. Rahman K, Siddiqui F A, Zaheer S, Sherwani M K A, Shahid M, Sherwani RK. cytology- Role in bone lesions. Diagnostic Cytopathology 2010; 38(9):639-44.

15. Rahman K, Sherwani RK, Azam Q, Sabir AB, Abbas M, Sherwani MKA. Role of intraoperative cytology in bone lesions. Surgery 2007; 17(22):33-37.

16. Rahman K. Platelet function test- From lab to clinical practice. J Int Med Ind- UP Chapter 2019, March 01; 12-14

17. Concurrent occurrence of Metastatic breast carcinoma and acute myeloid leukemia in bone marrow. Qayoom S, Gupta R, Singh P, Gupta A, Rahman K. Journal of cancer research and therapeutics. 2020;16;194-195

18. Rahman K, Singh P, Chandra D, Yadav DD, Gupta R, Gupta A. Early T cell Precursor Acute Lymphoblastic Leukemia with Auer Rods- A case Report. Int J Lab Hematol. 2020;42:e27-29.doi: 10.1111/ijlh.13084.

19. Gupta R, Yadav D, Chandra D, Rahman K. Spindle cell myeloma: A masquerader. Ind J HematBldTransfus 2019;35:382-83.

20. Kumar P, Rahman K, Singh MK, Gupta R, Nityanand S. Primary prostatic NHL- report of an unusual case. J Can Res Ther. 2019;15:178-179

21. Rahman K, Harankhedkar S, Gupta R, Gupta T, Sharma S, SoniyaNityanand. Microfilariae in a case of myelofibrosis. A cause or an association. J Can Res Ther. 2020;16:164-167

22. Gupta R, Mittal N, Rahman K, Sharma Akhilesh, Singh P, Sanjeev, Nityanand S. Rare BCR-ABL1 transcript in a RUNX1-RUNX1T1 positive de novo acute myeloid leukemia: The chicken and egg tale. Int J Lab Hematol. 2018;40:e24-e27. DOI.10.1111/ijlh.12779

23. Gupta T, Gupta R, Mittal N, Rahman K, Nityanand S. B-acute Lymphoblastic Leukemia with Bright CD45 and Moderate Side Scatter Simulating Monocytoid Population: An Unusual Phenotype. Indian J Hematol Blood Transfus 2018 Apr;34(2):358-359. doi: 10.1007/s12288-017-0896-7

24. Kumar P, Rahman K, Surabhi, Singh MK, Gupta R, Nityanand S. Priapism as a presentation of Chronic myeloid leukemia. Journal of Cancer research and Therapeutics. 2016, Ahead of Print.

25. Rahman K, Manish K Singh, Ruchi Gupta, SarjanaDutt, SoniyaNityanand. De novo Philadelphia Chromosome positive Myelodysplastic Syndrome: report of two cases with review of literature. Journal of Cancer research and Therapeutics. 2016, Ahead of Print. (IF-0.778)

26. Rahman K, Kumari S, Gupta R, Singh MK, Yadav G, Kumari N et al. Atypical Presentation of Hairy cell Leukmeia- Role of CD200. Journal of Cancer research and Therapeutics 2016, Ahead of Print.

27. Gupta R, Singh MK, Rahman K, Sharma S. Microangiopathic Hemolyticanemia associated with bone marrow metastasis in a12 Yr child.. Bone marrow research 2016;4:2

28. Gupta R, Aggarwal G, Rahman K, Singh MK, Nityanand S. Acute myeloid leukemia following radioiodine therapy: Case report and brief literature review. Clin Cancer Investig J 2016; 5:246-9.

29. Singh MK, Gupta R, Rahman K, Sanjeev, Sharma A, Nityanand S. Co-existence of AML1-ETO and BCR-ABL1 transcripts in a relapsed patient of acute myeloid leukemia with favorable risk group: A coincidence or clonal evolution? Hematol once stem cell therapy 2017; 10:39-41.

30. Yadav G, Rahman K, Gupta R, Nityanand S. Neutrophil Erythrocyte Rosettes: An unusual manifestation of Autoimmune HemolyticAnemia. Indian Journal of Hematology and Blood Transfusion 2016;32(Supplement 1): 309-10.

31. Qayoom K, Durga G, George S, Rahman K.Blastic plasmacytoid Dendritic cell neoplasm with primary leukemic involvement without cutaneous lesion- Report of a case with brief literature review. Ind J PatholMicrobiol2015;58(2):377-80.

32. Rahman K, Kamboj M, Khurana A, Qayoom S. 8p11 Myeloproliferative syndrome (EMS) a report of this rare clinical entity. Ind J PatholMicrobiol2015;58:254-5.

33. Surabhi, Rahman K, Singh MK, Gupta R. Leishmania donovani bodies in neutrophils on a Peripheral blood smear examination – Report of an unusual incident in a clinically unsuspected case. Ind J PatholMicrobiol2015;58:262.

34. Singh MK, Gupta R, Surabhi, Rahman K. Auer rods in polymorphs in a case of acute myeloid leukemia. Clin Cancer Inv Journal 2015;4(3); 476-8.

35. Gupta R, Hussain N, Rahman K, Nityanand S. Plasma cell myeloma with unusual morphology–A series of 6 cases. European Journal of Haematology 2014; 93: 165–170.

36. Rahman K, George S, Mangal S, Mehta A. Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: Report of an unusual case. Indian J PatholMicrobiol 2013;56:453-6.

37. Rahman K, George S, Tewari A, Mehta A. Mixed phenotypic acute leukemia with two immuophenotypically distinct blast population (B&T)- report of an unusual case. Cytometry Part B (Clinical Cytometry) 2013;84B:198–201

38. Rahman K, George S, Sardana M, Mehta A. Microfilariae with Acute Myeloid Leukemia- A common parasite with uncommon association.. Indian J Hematol Blood Transfus 2013, 29(2):113–115

39. Rahman K, Menon S, Patil A, Desai SB, Bakhshi G. A rare case of plasmacytoid urothelial carcinoma of bladder: diagnostic dilemmas and clinical implications. Indian journal of urology 2011;27:144-6

40. Rahman K, Naim M, Farooqui MR, Myecetoma of hand- an unusual presentation. The Internet Journal of Dermatology 2010 Volume 8 Number 1.

Book Chapters

1. Manish K Singh &Khaliqur Rahman. Approach to the Diagnosis of Acute Leukemia: In Tilak V, Bharti A, Singh A, Rani D eds. Hematology Classic and New. Pp 57-67. ISBN: 978-81-942340-9-8

2. Rahman K and Chandra D. Historical investigations and advances in Flow Cytometry Based tests in Paroxysmal Nocturnal Hemoglobinuria. Chapter no 6. In R Saxena and H P Pati Eds. Hematopathology. Springer Nature, Singapore. 2019. pp- 91-107

3. Gupta R and Rahman K. Role of micro RNA in Normal and Malignant Hematopoiesis. Chapter 26. In R Saxena and H P Pati Eds. Hematopathology. Springer Nature, Singapore. 2019.pp 435-448

4. Chandra D, Rahman K, Gupta R. Enumeration of CD34+ Hematopoietic stem cells by Flow Cytometry. Chapter 17 pp244-255. In Abhishek Purohit and GK Bohra eds Hematology Pearls 2018.

1. Chandra D, Singh J, Deka R, Ahuja A, Sharma R, Pati HP et al. T regulatory cells in donor grafts m ay predict the severity of acute graft versus host disease after matched sibling donor allogenic peripheral blood stem cell transplantation. Indian J Hematol Blood Transfus 2019;35(2):233-239. doi: 10.1007/s12288-018-01071-9.

2. Chandra D, Singh J, Deka R, Chauhan R, Sazwal S, Mishra P, et al. The biology of chronic myelogenous leukemia in childhood and young adolescents: An Indian perspective. Indian J Med Paediatr Oncol 2018;39:142-5. doi: 10.4103/ijmpo.ijmpo-62-17

3. Chandra D, Tyagi S, Singh J, Deka R, Manivannan P, Mishra P, Pati H, Saxena R. Utility of 5-Methylcytosine Immunohistochemical Staining to Assess Global DNA Methylation and Its Prognostic Impact in MDS Patients. Asian Pac J Cancer Prev2017;18:3307-331. dio:10.22034/APJCP.2017.18.12.3307

4. Chandra D, Tyagi S, Deka R, Chauhan R, Singh J, Seth T, et al. Utility of screening golf ball inclusions in hemoglobin H040 disease and its clinico-hematological profile. J ApplHematol2017;8:135-9. doi: 10.4103/joah.joah_46_17.

5. Pasvan V, Chandra D, Gupta R, Qayoom S, Nityanand S. Unusual Visitor in Bone Marrow- Metastatic Malignant Melanoma Indian J Hematol Blood Transfus. 2020. DOI 10.1007/s12288-020-01364-y

6. Chandra D, Dhingra B, Seth T, Mishra P, Bansal D, Mahapatra M, Pati HP. Congenital Hypotransferrinemia, an Unusual Cause of Iron Deficiency Anemia: Report of Two Cases. Indian J Hematol Blood Transfus2017;33(3):402–404. doi:10.1007/s12288-016-0746-z

7. Chandra D, Tyagi S, Deka R, Chauhan R, Seth T, Saxena R, Pati HP. A Novel Double Heterozygous Hb D-Punjab/Hb J-Meerut Hemoglobinopathy.Indian J Hematol Blood Transfus. 2017;33(4):611-613.doi.10.1007/s12288-016-0763-y.

Book Chapters:

1. Dinesh Chandra, Ruchi Gupta. Role of Laboratory in Hematopoietic Stem Cell Transplantation.Chapter no. 24 In R Saxena and H P Pati Eds. Hematopathology. Springer Nature, Singapore. 2019.page no 406-416.

2. Chandra D, Rahman K, Gupta R. Enumeration of CD34+ Hematopoietic stem cells by Flow Cytometry. Chapter 17 pp244-255. In Abhishek Purohit and GK Bohra eds Hematology Pearls 2018.

3. Ruchi Gupta, Dinesh Chandra. Approach to chronic lymphoproliferative disorders by flow cytometry: In Tilak V, Bharti A, Singh A, Rani D eds. Hematology Classic and New. Pp 57-67. ISBN: 978-81-942340-9-8

4. Rahman K and Chandra D. Historical investigations and advances in Flow Cytometry Based tests in Paroxysmal Nocturnal Hemoglobinuria. Chapter no 6. In R Saxena and H P Pati Eds. Hematopathology. Springer Nature, Singapore. 2019.

5. Gupta R, Chandra D, Rahman K. Thrombotic Thrombocytopenic Purpura. Chapter 17 pp244-255. In Abhishek Purohit and GK Bohra eds Hematology Pearls 2019

1.Sujeet Kumar, Sanjeev, Khaliqur Rahman, Manish Kumar Singh, Dinesh Chandra, Anshul Gupta, Ruchi Gupta, Rajesh Kashyap & Soniya Nityanand Waldenström Macroglobulinemia: Clinico-pathological Profile and Treatment Outcomes of Patients from a Tertiary Care Centre of North India. https://doi.org/10.1007/s12288-020-01382-w

2. Gupta R, Sanjeev, Parashar Y, et al. Morphological characteristics, cytogenetic profile, and outcome of RUNX1-RUNX1T1-positive acute myeloid leukemia: Experience of an Indian tertiary care center. Int J Lab Hematol. 2020;42(1):37–45. doi:10.1111/ijlh.13121

1. Singh MK, ASN Remani, Bhave SJ, Mishra DK, Arora N, Parihar M. Detection of BCR/PDGRFα Fusion Using Dual Colour Dual Fusion BCR/ABL1 Probe: An Illustrative Report. Indian J Hematol Blood Transfus 2019

2. M Parihar, MK Singh, R Islam, D Saha, DK Mishra, V Saha, S Krishnan. A triple‐probe FISH screening strategy for risk‐stratified therapy of acute lymphoblastic leukaemia in low‐resource settings. Pediatric blood & cancer, 2018.

3. Gupta R, Singh Manish K, Rahman K, Kumari S, Yadav G, Nityanand S. Utility of a single tube six color flow cytometry panel for the diagnosis of Myelodysplastic Syndrome: Experience of tertiary care center in India. Int J HematolOncol Stem Cell Res. 2018

4. Singh Manish K, Parihar M, Arora N, Mishra Deepak K, BhaveSaurabh J, Chandy M. Diagnosis of variant RARA translocation using standard dual-color dual-fusion PML/RARA FISH probes: An illustrative report. HematolOncol Stem Cell Ther 2017

5. Singh MK, Gupta R, Rahman K, Yadav G, Sharma A, Nityanand S. De novo Philadelphia positive acute myeloid leukemia with extensive basophilia: a diagnostic dilemma. Indian J Hematol Blood transfuse 2016

6. Singh MK, Gupta R, Rahman K, Kumar S, Sharma A, Nityanand S. Co-existence of AML1-ETO and BCR-ABL1 transcripts in a relapsed patient of acute myeloid leukemia with favorable risk group: A coincidence or clonal evolution? HematolOncol Stem Cell Ther 2016

7. Singh MK, Gupta R, Rahman K, Surabhi. Auer rods in polymorphs in case of AML. Clin Cancer Investig J 2015

8. Singh MK, Goel MM, Singh US, Dalela D, Shankhwar SN, Kumar A. Detection of bone marrow metastases in prostate cancer: Role of trephine biopsy and immunohistochemistry. Clin Cancer Investig J 2013

9. Singh MK, Tondon P, Natu SM, Ali W, Mehrotra R. Transient congenital hypothyroidism: a rare case. Biomed Res 2011

1. Chaturvedi CP, Tripathy NK, Minocha E, Sharma A, Rahman K , and Nityanand S. Altered Expression of Hematopoiesis Regulatory Molecules inLipopolysaccharide-Induced Bone Marrow Mesenchymal StemCells of Patients with Aplastic Anemia. Stem Cells InternationalVolume 2018, Article ID 6901761, 7 pages

2. Tripathy NK, Rizvi SHM, Singh SP, Srikanth GVN and Nityanand S, Cardiomyogenic Heterogeneity of Clonal Subpopulations of Human Bone Marrow Mesenchymal Stem Cells. J Stem Cells Regen Med, 2018; 14: 27-33

3. Tripathy NK, Saurabh Pratap Singh, and SoniyaNityanand. Enhanced Adipogenicity of Bone Marrow Mesenchymal Stem Cells in Aplastic Anemia. Stem Cell International, 2014; Article ID 276862,6 pages.

4. Tripathy NK, Chandran V, Garg NK, Sinha N and Nityanand S. Soluble Endothelial Cell Adhesion Molecules and their Relationship with Disease Activity in Takayasu’s Arteritis. J Rheumatol, 2008; 35:1842-5

5. Tripathy NK and Nityanand S. High TNF-positiveand low IL-2 negative T-cells characterize active disease in Takayasu’s arteritis. Clin Immunol, 2006; 118: 154-8.

6. Tripathy NK, Vibhuti and Nityanand S. Bone marrow and Blood plasma levels of IL-8 in Aplastic anemia and their relationship with disease severity. Am J Hematol, 2005, 79: 1-3.

7. Tripathy NK, Sinha N and Nityanand S. Interleukin-8 in Takayasu’s arteritis: Plasma levels and their relationship with disease activity. Clin Exp Rheumatol, 2004, 22 (Suppl-36): S27-30.

8. Tripathy NK and Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu’s arteritis. Clin Exp Immunol, 2004; 138: 369-74.

9. Tripathy NK, Sinha N and Nityanand S.Anti-annexin-V antibodies in Takayasu’s arteritis: prevalence and relationship with disease activity. Clin Exp Immunol, 2003, 134: 360-4.

10. Tripathy NK, Sinha N and Nityanand S. Anti-monocyte antibodies in Takayasu’s arteritis: prevalence and relation with disease activity. J Rheumatol, 2003, 30: 2023-6.

11. Tripathy NK, Upadhyaya S, Sinha N and Nityanand S. Complement and cell mediated cytotoxicity by anti-endothelial cell antibodies in Takayasu arteritis. J Rheumatol, 2001; 28: 805-8.

Book Chapter

1. Tripathy NK and Nityanand S “Regenerative Medicine, API Textbook of Medicine, 11th Edition, 2019

1. Kulwant Singh&Chandra Prakash Chaturvedi. Stem Cell Aging: An Epigenetic Perspective. (Invited book chapter: Nova Publication,Current Challenges And Management Of Diseases In The Elderly Population,2020, page-1-56). (Corresponding author)

1. Chaturvedi CP,Tripathy NK, Minocha E, Sharma A, Rahman K and Nityanand S (2018) Altered Expression of Hematopoiesis Regulatory Molecules in Lipopolysaccharide- Induced Bone Marrow Mesenchymal Stem Cells of Patients with Aplastic Anemia, Stem Cells International Article ID 6901761, Volume 2018 (* Equal Contribution)

2. ChaturvediC.P&BrandM.(2014)Structuredreview/cardon:EHMT2/G9a(6p21.33).Atlas Genet CytogenetOncolHaematol. 2014; 18(1), 38-45

3. ChaturvediC.P,SomasundaramB,SinghK,CarpenedoR,WilliamL.Stanford,DilworthJ&BrandM.(2012)Maintenanceofgenesilencingbythecoordinateactionofthe H3K9methyltransferaseG9a/KMT1CandtheH3K4demethylaseJarid1a/KDM5A.PNAS, Nov 13; 109(46): 18845-50.

4. Chaturvedi C.P*, Hosey AM*, Palii C, Perez-Iratxeta C, Nakatani Y, Ranish JA, Dilworth FJ & Brand M. (2009) Dual role for the methyltransferase G9a in the maintenance of ß-globin gene transcription in adult erythroid cells. PNAS 106(43): 18303-8 *Co-authors

5. Chaturvedi, C.P.,Lodhi,N., Ansari,S.A., Sawant,S.V. andRakeshTuli(2007) Mutated TATA –box/TBP complementation system for regulated transgene expression in tobacco. Plant Journal 50; 917-25

6. Chaturvedi, C.P., Sawant, S.V., Kiran, K., Mehrotra, R., Ansari, S.A., Lodhi, N. and Tuli, R. (2006) Analysis of polarity in the expression from a multifactorial bidirectional promoter designed for high level expression of transgenes in plant. J.Biotechnology123;1-12.

7. Chaturvedi, C.P.* & Chand, L. (2001) Efficient plantlet regeneration in chickpea.International Chickpea and Pigeonpea, News Letter 8, 21-22. *Corresponding Author

1. Tabassum, N.,Verma, V., Kumar, M. et al. Cell Tissue Res (2018).Nanomedicinein cancer stem cell therapy: from fringe to forefront.374(3): 427. doi.org/10.1007/s00441-018- 2928-5.(Correspondingauthor)

2. Anshuman Singh.,C.B.Yadav.,N.Tabassum., A.K.Bajpeyee., V.Verma. Europian journal of cell biology.(2018). Stem cell niche: Dynamic neighbor of stem cells.doi.org/10.1016/j.ejcb.2018.12.001.(Correspondingauthor).

3. Verma V, Tabassum N, Yadav CB, Kumar M, Singh AK, Singh, M.P. et al. (2016). Cord Blood Banking: An Indian Perspective. Cell MolBiol62:3. doi: 10.4172/1165-158X.1000133.

4. Verma V*, Mehta A*, Nandihalli M, Ramachandra CJA, Sequiera GL, et al. (2014) A Systemic Evaluation of Cardiac Differentiation from mRNA reprogrammed Human Induced Pluripotent Stem Cells. PLoS ONE9(7):e103485.doi:10.1371/journal.pone.0103485.*These authors contributed equally

5. Vinod Verma, Kristy Purnamawati, Manasi, WinstonShim. (2013). Steering signal transduction pathway towards cardiac lineage from human pluripotent stem cells. Cell. Signal. 25(5),1096-1107.

6. Verma, V.; Huang, B.; Kallingappa P.K.; Oback, B. (2013). Dual kinase inhibition promotes pluripotency in finite bovine embryonic cell lines. Stem Cell Dev. 22(11): 1728-1742

7. Verma V, Gautam S K, Singh B, Manik R S, Palta P, Singla S.K, GoswamiS L and Chauhan M S. 2007: Isolation and characterization of embryonic stem cell like cells from in vitro produced bubaline emryos. MolReprodDev74: 520-529.

8. Verma V, Gautam S K, Manik R S, Palta P and Chauhan M.S. 2008.Development of a pronuclear DNA microinjection technique for production of green fluorescent protein-expressing bubaline (Bubalusbubalis) embryos.Theriogenology69(6):655-65

1. Kulwant Singh& Chandra Prakash Chaturvedi. Stem Cell Aging: An Epigenetic Perspective. (Invited book chapter: Nova Publication,Current Challenges And Management Of Diseases In The Elderly Population,2020, page-1-56).(First and Corresponding)

2. Singh K*, HussainI, Mishra V, &Akhtar MS*. New insight on 8-anilino-1-naphtalene sulfonic acid interaction with TgFNR hydrophobic exposure analysis. Int J BiolMacromol. 2019 Feb 1; 122:636-643. (*Shared corresponding author).

3. Singh K, Cassano M, Planet E, Sebastian S, Jang SM, Sohi G, Faralli H, Choi J, Youn HD, Dilworth FJ, and Trono D. A KAP1 phosphorylation switch controls MyoD function during skeletal muscle differentiation. Genes& Development.2015; 29:513-525.

4. Singh K, Dilworth FJ. Differential modulation of cell cycle progression distinguishes members of the myogenic regulatory factor family of transcription factors. FEBS J 2013;280(17): 3991-4003.

5. Singh K, Dilworth FJ. Redirecting traffic in the nucleus. Developmental Cell 2011; 13;21(3): 390-2.

6. Singh K*, Bhakuni V. Guanidine hydrochloride and urea induced unfolding of Toxoplasmagondiiferredoxin-NADP(+) reductase: stalilization of a functionally inactive holo-intermediate. J Biochem. 2009;145 (6): 721-31. (*Corresponding author)

7. Singh K, Bhakuni V. Toxoplasma gondiiferredoxin-NADP (+) reductase: Role of ionic interactions in stabilization of native conformation and structural cooperativity. Proteins. 2008;71: 1879-1888.

8. Singh K, Bhakuni V. Cation induced differential effect on structural and functional properties of Mycobacterium tuberculosis alpha-isopropylmalate synthase. BMC Struct. Biol. 2007;19; 7:39.

1. Diamanti, M. A.*, Gupta, J.*,Bennecke, M., De Oliveira, T., Ramakrishnan, M., Braczynski, A. K., Richter, B., Beli, P., Hu, Y., Saleh, M., et al. (2017). IKKalpha controls ATG16L1 degradation to prevent ER stress during inflammation. Journal of Experimental Medicine 214, 423-437. (Impact Factor: 10.89; Citations: 30) ISSN No. 1540-9538 *equal contribution

2. Gupta, J., and Nebreda, A.R. (2015). Roles of p38alpha MAPK in mouse models of inflammatory diseases and cancer. FEBS J 282(10):1841-1857. (Impact Factor: 4.73; Citations: 67) ISSN No. 1742-4658

3. Gupta, J.,Igea, A, Papaioannou, M., Lopez-Casas, P.P., Llonch, E., Hidalgo, M., Gorgoulis, V.G., and Nebreda, A.R. (2015). Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors. Oncotarget 6(11):8539-8551. (Impact Factor: 5.16; Citations: 24) ISSN No. 1949-2553

4. Gupta, J., del Barco Barrantes, I., Igea, A., Sakellariou, S., Gorgoulis, V. G., and Nebreda, A. R. (2014). Dual function of p38alpha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. Cancer Cell 25, 484-500. (Impact Factor: 23.91; Citations: 97) ISSN No. 1878-3686